Sign in

CIK 0001623526

  • Non-accelerated filer
  • Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471144582
Phone
+1 781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$403,975
in 4 filings, $404K under 10b5-1 plans

Net −$403,975. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-11-02 Nash Huw M. COO & CBO Sale −3,164 $36.59 $116K 2,536
2020-11-02 Nash Huw M. COO & CBO Sale −2,536 $37.98 $96K 0
2020-11-02 Nash Huw M. COO & CBO Exercise or conversion · Employee Stock Option (Right to Buy) −5,700 150,211
2020-10-19 Liau Gene EVP Research & Preclinical Dev Exercise or conversion +30,497 $0.60 $18K 43,997
2020-10-19 Liau Gene EVP Research & Preclinical Dev Exercise or conversion +1,503 $2.19 $3K 45,500
2020-10-19 Liau Gene EVP Research & Preclinical Dev Sale −24,775 $37.64 $933K 20,725
2020-10-19 Liau Gene EVP Research & Preclinical Dev Sale −7,225 $38.42 $278K 13,500
2020-10-19 Liau Gene EVP Research & Preclinical Dev Exercise or conversion · Employee Stock Option (right to buy) −30,497 96,069
2020-10-19 Liau Gene EVP Research & Preclinical Dev Exercise or conversion · Employee Stock Option (right to buy) −1,503 70,386
2020-10-16 Liau Gene EVP Research & Preclinical Dev Exercise or conversion +5,851 $0.60 $4K 19,351
2020-10-16 Liau Gene EVP Research & Preclinical Dev Sale −5,851 $40.00 $234K 13,500
2020-10-16 Liau Gene EVP Research & Preclinical Dev Exercise or conversion · Employee Stock Option (right to buy) −5,851 126,566
2020-10-13 Liau Gene EVP Research & Preclinical Dev Exercise or conversion +1,649 $0.60 $989 15,149
2020-10-13 Liau Gene EVP Research & Preclinical Dev Sale −1,649 $40.00 $66K 13,500
2020-10-13 Liau Gene EVP Research & Preclinical Dev Exercise or conversion · Employee Stock Option (right to buy) −1,649 132,417
2020-10-01 Nash Huw M. COO & CBO Exercise or conversion +5,700 $2.19 $12K 5,700
2020-10-01 Nash Huw M. COO & CBO Sale −3,400 $34.33 $117K 2,300
2020-10-01 Nash Huw M. COO & CBO Sale −2,300 $34.86 $80K 0
2020-10-01 Nash Huw M. COO & CBO Exercise or conversion · Employee Stock Option (Right to Buy) −5,700 155,911
2020-09-09 Nash Huw M. COO & CBO Exercise or conversion +17,201 $2.19 $38K 17,201

Page 29 of 35 · 681 trades